Mobile Site ›

Test Catalog

Test ID: VHLD    
Von Hippel-Lindau (VHL) Deletion Detection

NY State Approved Indicates the status of NY State approval and if the test is orderable for NY State clients.


Useful For Suggests clinical disorders or settings where the test may be helpful

Diagnosis of suspected Von Hippel-Lindau disease


Screening presymptomatic members of Von Hippel-Lindau families


Tailoring optimal tumor-surveillance strategies for patients, when used in conjunction with phenotyping

Testing Algorithm Delineates situation(s) when tests are added to the initial order. This includes reflex and additional tests.


Special Instructions and Forms Describes specimen collection and preparation information, test algorithms, and other information pertinent to test. Also includes pertinent information and consent forms to be used when requesting a particular test

Method Name A short description of the method used to perform the test

Polymerase Chain Reaction (PCR) Amplification/Deletion Detection by Multiplex Ligation-Dependent Probe Amplification (MLPA)
(PCR is utilized pursuant to a license agreement with Roche Molecular Systems, Inc.)

Reporting Name A shorter/abbreviated version of the Published Name for a test; an abbreviated test name

VHL Deletion Detection

Aliases Lists additional common names for a test, as an aid in searching

VHL (von Hippel-Lindau) Gene
Von Hippel Lindau familial cancer syndrome
Von Hippel Lindau tumor suppressor